More stories
-
Lenvatinib Combo Improves Clinical Benefit in Clear Cell RCC Subgroups
Combination of Lenvatinib and Pembrolizumab Improves Clinical Benefits Over Sunitinib in Clear Cell Renal Cell Carcinoma Patients The phase 3 CLEAR trial has shown that the combination of lenvatinib, marketed as Lenvima, and pembrolizumab, marketed as Keytruda, provides superior clinical benefits compared to sunitinib, marketed as Sutent, in patients with advanced clear cell renal cell […] More
-
Simplifying Subcutaneous Drug Administration SCHOTT Pharma and KORU – Morningstar
SCHOTT Pharma and KORU Medical Systems Partner to Offer High-Volume Subcutaneous Drug Infusion Solution Introduction SCHOTT Pharma and KORU Medical Systems have formed a partnership to develop a high-volume subcutaneous drug infusion solution that will make it easier and safer for patients and healthcare providers to administer large volume doses of medications. About SCHOTT Pharma […] More
-
Judge slashes Bayer’s massive $2B Roundup verdict to $400M on TradingView
Bayer to Appeal Against Jury Decision Linking Roundup to Cancer Introduction Bayer has expressed its intention of appealing to the Superior Court of Pennsylvania following a jury’s finding that a man’s non-Hodgkin’s lymphoma was caused by his long-term use of Roundup, an herbicide produced by former Monsanto, the US company Bayer acquired in 2018. The […] More
-
“Are Biosimilars as Effective as Original Anti-VEGF Medicines? Cochrane Investigates”
Anti-VEGF Biosimilars: A Viable Alternative for Treating Neovascular Age-Related Macular Degeneration Introduction Neovascular age-related macular degeneration (nAMD) is a common eye disease that can lead to vision loss. The approved treatment for nAMD involves regular injections of anti-vascular endothelial growth factors (anti-VEGFs) into the eye, which can be expensive and require frequent visits to the […] More
-
Aspirin Adjuvant Therapy for Breast Cancer
No Benefit of Adjuvant Aspirin for High-Risk Nonmetastatic Breast Cancer, Study Shows Introduction A recent Phase III trial showed that daily low-dose aspirin does not improve breast cancer recurrence or survival in patients with high-risk nonmetastatic breast cancer. Wendy Y. Chen, MD, MPH, and colleagues conducted the study, which was eventually suspended early due to […] More
-
Halsey Shares Life with Lupus and Rare Lymphoma Disorder on TheWrap
Halsey Reveals Struggle with Lupus and Rare Lymphoma Disorder Popular singer and actress Halsey recently took to social media to confirm that she has been dealing with Lupus and a rare T-cell lymphoproliferative disorder. In an Instagram post, she revealed that she was first diagnosed with Lupus in 2022, followed by the lymphoma disorder. Halsey’s […] More
-
Revolutionary Treatment for Lingual Hematoma in End-Stage Renal Disease Patients
Improving Patient Care: Alternative Medicine for Chronic Pain Management Introduction Chronic pain is a condition that can seriously affect a patient’s quality of life. Conventional pain management treatments include medications like opioids, which can lead to dependence and addiction. As a result, more and more patients are seeking alternative medicine for pain management. Acupuncture Acupuncture […] More
-
Beebe Healthcare Enhances Procedures with Robotic-Assisted Navigational Bronchoscopy
Finding the Best Healthcare Treatments and Alternatives Healthcare is an essential aspect of life as it pertains to the maintenance of physical and mental wellbeing. Everyone wants to live a healthy and fulfilling life, but it can be challenging when you are faced with illness or injury. In today’s world, there are various healthcare treatments […] More
-
Armored CART Therapy Shows Promise for Liver Cancer
Next-generation CAR-T therapy shows promising results for advanced liver cancer A recent study presented at the American Society of Clinical Oncology Annual Meeting (ASCO 2024) showed that a new next-generation CAR-T therapy called C-CAR031 could potentially offer hope for patients with advanced hepatocellular carcinoma (HCC). Understanding Hepatocellular Carcinoma (HCC) Hepatocellular Carcinoma (HCC) is the most […] More
-
Halsey Reveals Illness in New Song Saying They Are Lucky to Be Alive
Halsey Opens Up About Lupus and T-Cell Lymphoproliferative Disorder Diagnosis Halsey, the American singer and songwriter, took to social media on Wednesday, 13th April 2022, to announce that she had been diagnosed with two medical conditions; lupus and a rare T-cell lymphoproliferative disorder. The multi-platinum star whose preferred pronouns are she/they wrote on Instagram that […] More
-
Avinger Boosts Efforts in Coronary Development, Trims Operating Costs of Peripheral
Avinger, Inc. announces increase in focus on coronary artery disease program Avinger, Inc., a commercial-stage medical device company developing and marketing catheter-based systems for the diagnosis and treatment of vascular diseases, has announced its decision to increase its focus on its coronary artery disease program. The company will develop an innovative new image-guided therapeutic system […] More
-
Scaling Back Cancer Treatment for 3 Types is Safe and Effective finds Studies
Scaling Back Treatment for Some Cancers: The Latest in Cancer Research Scaling Back Treatment for Some Cancers: The Latest in Cancer Research Doctors have reported at the American Society of Clinical Oncology annual meeting at McCormick Place that scaling back treatment for three kinds of cancer can make life easier for those facing the disease […] More
-
Trending
Studies on Briumvi in MS Patients During Pregnancy and Breastfeeding
TG Therapeutics Conducting Two Post-Marketing Studies on Briumvi During Pregnancy and Breastfeeding Introduction TG Therapeutics is conducting two post-marketing studies to evaluate the safety of Briumvi among people with relapsing forms of multiple sclerosis (MS) who are pregnant or breastfeeding, as well as their babies. The company aims to generate data on the use of […] More
-
FDA May 2024 Roundup A Month of Progress in Cancer Treatment and Detection
Advancements in Cancer Treatment and Detection Approvals by the FDA in May 2024 Introduction May 2024 saw noteworthy advancements in several areas, including a significant number of FDA approvals, designations, and clearances related to cancer treatment and detection. The following is a detailed overview of the significant approvals and designations from the FDA. FDA Approvals […] More
-
FDA Chooses Moderna’s Rare Disease Candidate for Accelerated Development Program
Moderna’s mRNA-3705: Investigational Therapeutic for Methylmalonic Acidemia (MMA) Moderna Therapeutics, a biotechnology company pioneering the development of mRNA-based medicines, is advancing a novel therapeutic targeting methylmalonic acidemia (MMA) due to methylmalonic-CoA mutase (MUT) deficiency. The investigational therapeutic is known as mRNA-3705, which is designed to instruct the body to restore the missing or dysfunctional proteins […] More
-
Linking Malignant Lymphoma to Tattoos: A New Study Reveals the Connection
Tattoos and Lymphoma: What the Latest Research Reveals The Study’s Findings and Implications A recent study conducted by Lund University’s research team in Sweden reveals that individuals with tattoos may have a greater risk of developing malignant lymphoma, which affects the lymphatic system. However, experts caution that further investigation is needed to establish a definitive […] More
Load More
Congratulations. You've reached the end of the internet.